Valuation Mesa Laboratories, Inc.
Stocks
MLAB
US59064R1095
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 100.81 USD | -0.23% |
|
+3.39% | +28.42% |
Company Valuation: Mesa Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,337 | 934.1 | 591.9 | 644.8 | 488.5 | 564.1 | - |
| Change | - | -30.14% | -36.64% | 8.93% | -24.23% | 15.48% | - |
| Enterprise Value (EV) | 1,506 | 1,084 | 591.9 | 644.8 | 488.5 | 564.1 | 564.1 |
| Change | - | -27.99% | -45.42% | 8.93% | -24.23% | 15.48% | 0% |
| P/E | 728x | 1,028x | -2.32x | -330x | 73.1x | 74.1x | 47x |
| PBR | 3.41x | 2.38x | 4.07x | 4.05x | 2.62x | 2.69x | 2.49x |
| PEG | - | -20x | 0x | 3.3x | -0x | 6x | 0.8x |
| Capitalization / Revenue | 7.25x | 4.26x | 2.74x | 2.68x | 1.96x | 2.18x | 2.07x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 2.18x | 2.07x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 8.93x | 8.41x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 8.59x | 8.01x |
| EV / FCF | 0x | 0x | 0x | 0x | 0x | 14.1x | 12.7x |
| FCF Yield | 2.6% | 2.51% | 7.02% | 6.6% | 8.1% | 7.09% | 7.85% |
| Dividend per Share 2 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 |
| Rate of return | 0.25% | 0.37% | 0.58% | 0.54% | 0.72% | 0.63% | 0.63% |
| EPS 2 | 0.35 | 0.17 | -47.2 | -0.36 | 1.21 | 1.36 | 2.143 |
| Distribution rate | 183% | 376% | -1.36% | -178% | 52.9% | 47.1% | 29.9% |
| Net sales 1 | 184.3 | 219.1 | 216.2 | 241 | 249.1 | 259.2 | 272.2 |
| EBITDA 1 | 41.16 | 49.68 | 50.5 | 56.74 | 63.49 | 63.2 | 67.1 |
| EBIT 1 | 37.9 | 45.82 | 50.5 | 51.36 | 58.23 | 65.7 | 70.4 |
| Net income 1 | 1.871 | 0.93 | -254.2 | -1.974 | 6.712 | 7.567 | 12.13 |
| Net Debt | 169 | 150.4 | - | - | - | - | - |
| Reference price 2 | 254.88 | 174.73 | 109.73 | 118.66 | 88.42 | 100.81 | 100.81 |
| Nbr of stocks (in thousands) | 5,246 | 5,346 | 5,394 | 5,434 | 5,525 | 5,596 | - |
| Announcement Date | 31/5/22 | 25/5/23 | 5/6/24 | 28/5/25 | 27/5/26 | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 74.29x | - | - | 0.63% | 564M | ||
| 30.24x | 4.11x | 15.98x | 2.44% | 183B | ||
| 19.42x | 3.39x | 11.94x | 3.47% | 109B | ||
| 17.37x | 0.19x | 12.26x | 0.76% | 60.57B | ||
| 30.04x | 7.29x | 19x | 1.33% | 51.8B | ||
| 36.03x | 3.22x | 10.97x | 2.37% | 45.64B | ||
| 37.5x | 1.37x | 12.06x | 0.21% | 33.22B | ||
| 30.28x | 5.41x | 17.22x | -.--% | 31.49B | ||
| 39.6x | 6.94x | 24.84x | 0.27% | 24B | ||
| 24.62x | 3.73x | 13.08x | 1.13% | 22.26B | ||
| Average | 33.94x | 3.96x | 15.26x | 1.26% | 56.17B | |
| Weighted average by Cap. | 27.85x | 3.79x | 14.76x | 1.94% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- MLAB Stock
- Valuation Mesa Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
















